CORC

在结果中检索

CORC

浏览/检索结果: 共8条，第1-8条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy 期刊论文
BRITISH JOURNAL OF SURGERY, 2019, 卷号: 106, 期号: 2
作者:  Thomas, Hannah S.;  Weiser, Thomas G.;  Drake, Thomas M.;  Knight, Stephen R.;  Fairfield, Cameron
收藏  |  浏览/下载：143/0  |  提交时间：2019/12/05
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study 期刊论文
LANCET INFECTIOUS DISEASES, 2018, 卷号: 18, 期号: 5
作者:  Bhangu, Aneel;  Ademuyiwa, Adesoji O.;  Aguilera, Maria Lorena;  Alexander, Philip;  Al-Saqqa, Sara W.
收藏  |  浏览/下载：51/0  |  提交时间：2019/12/05
International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module 期刊论文
AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 卷号: 44, 期号: 12
作者:  Daniel Rosenthal, Victor;  Al-Abdely, Hail M.;  El-Kholy, Amani Ali;  AlKhawaja, Safa A. Aziz;  Leblebicioglu, Hakan
收藏  |  浏览/下载：52/0  |  提交时间：2019/12/13
Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab 期刊论文
CLINICAL CANCER RESEARCH, 2013, 卷号: 19, 期号: 9
作者:  Coiffier, Bertrand;  Li, Weimin;  Henitz, Erin D.;  Karkera, Jayaprakash D.;  Favis, Reyna
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study 会议论文
作者:  Coiffier, Bertrand;  Li, Weimin;  Henitz, Erin D.;  Karkera, J. D.;  Favis, Reyna
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19
Identification of patient subgroups demonstrating longer Progression-Free Survival (PFS) benefit with bortezomib-rituximab versus rituximab in patients with relapsed or refractory Follicular Lymphoma (FL): Biomarker analyses of the phase 3 LYM3001 study 期刊论文
Blood, 2011, 卷号: 118
作者:  Coiffier B., Li W., Henitz E.D., Karkera J.D., Favis R., Gaffney D., Shapiro A., Theocharous P., Elsayed Y.A., Van De Velde H., Osmanov E.A., Hong X., Scheliga A., Offner F.C., Rule S., Teixeira A.C.,
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial 期刊论文
LANCET ONCOLOGY, 2011, 卷号: 12, 期号: 8
作者:  Coiffier, Bertrand;  Osmanov, Evgenii A.;  Hong, Xiaonan;  Scheliga, Adriana;  Mayer, Jiri
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma 会议论文
作者:  Coiffier, Bertrand;  Osmanov, Evgenii;  Hong, Xiaonan;  Scheliga, Adriana;  Mayer, Jiri
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace